YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

In Vivo Screening Method for the Anti-AIDS Drugs in the BALB/c Mice Inoculated by Anemia Strain of Friend Virus

Friend Anemia Virus에 감염된 BALB/c 생쥐를 이용한 항AIDS약물의 생체내 약효검색

  • Published : 1995.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

Inoculation of Friend anemia virus, which was a Kind of retro virus such as HIV, results splenomegaly, anemia, the increase of WBC counts and reverse transcriptase activity in serum. These results were due to the inhibition of the differentiation of erythroid progenitor cell by the FVA at the spleen. Using these as index of antiviral effects, we pursued the establishment of in vivo screening method for the new anti-ADS drugs. Among zidovudine, didanosine and zalcitabine, which were already approved as anti-AIDS drugs, treatment of zidovudine for 18 days in BALB/c mice inoculated with Friend anemia virus resulted the most potent inhibitory effects on the splenomegaly, the increase of WBC counts and reverse transcriptase activity, but did not recovered the anemia due to the tomcity of zidovudhie itself on the bone marrow. The antiviral effects of zidovudine was reduced in case of zidovudine treatment 7 days after Friend anemia virus inoculation. These results suggested that the sooner treatment of zidovudine would be better improved when the virus was inoculated. Human recombinant interferon itself .alpha. did not showed the antiviral activity against Friend anemia virus and did not also affected the antiviral activity of zidovudine. These results suggested that Friend anemia virus would be used as a tool in vivo screening method for the Lobster of reverse transcriptase.

Keywords

References

  1. Science v.249 Molecular targets for AIDS therapy Mitsuya,H.;Broder,S.
  2. Proc. Natl. Acad. Sci. U.S.A. v.82 3'-Azido-3'-deoxythymidine(BW A509U):aan antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotrophic virus typeⅢ/lymphadenopathy-associated virus in vitro Mituya,H.;Weinhold,K.J.;Furman,P.A.;St.Clair,M.H.;Lehrman,S.N.;Gallo,R.C.;Bolognesi,D.;Barry,D.W.;Broder,S.
  3. Nature v.325 Strategies for antiviral therapy in AIDS Mitsuya,H.;Broder,S.
  4. Proc. Natl. Acad. Sci. U.S.A. v.83 Phosphorylation of 3'-azido-3'-deoxythymidine and selctive interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase Furman,P.A.;St.Clair,M.H.;Spector,T.
  5. N. Engl. J. Med. v.316 Development of antiretrovial therapy for the acquired immunodeficiency syndrome and related disorders Yarchoan,R.;Broder,S.
  6. Drug Metabolism and Disposition v.15 The disposition and metabolism of 2',3'-dideoxycytidine,an in vitro inhibitor of human Tlymphotrophic virus typeⅢ infectivity, in mice and monkeys Kelly,J.A.;Litterst,C.L.;Roth,J.S.;Vistica,D.T.;Poplack,D.G.;Cooney,D.A.;Nadkarni,M.;Balis,F.M.;Broder,S.;Johns,D.G.
  7. Biochem. Pharmacol. v.37 The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species Balzarini,J.;Pauwels,R.;Baba,M.;Herdewijn,P.;Clercq,E.;Broder,S.;Johns,D.G.
  8. Cancer Research v.47 3'-Azido-3'-deoxythymidine in feline leukemia virus-infected cats: A model for therapy and prophylaxis of AIDS Tavares,L.;Roneker,C.;Johnston,K,;Lehrman,S.N.;Noronha,F.
  9. Antimicrob. Agent Chemother v.34 3-Azido-3-deoxythymidine prevents induction of murine acquired immunodeficieny syndrome in C57BL/10 mice infected with LPBM5 murine leukemia viruses, a possible animal model for antiretrovial drug screening Ohnota,H.;Okada,Y.;Ushijima,H.;Kitamura,T.
  10. Annals New York Academy of Science Anti-viral therapy induces T cells which protect against viral challenge Ruprecht,R.M.;Mullaney,s.;Sosa,G.;Hom,R.;Finberg,R.
  11. J. Antibiotics v.40 Screening for inhibitors of avian myeloblastosis virus reverse transcriptase and effect on the replication of AIDS-virus Inouye,Y.
  12. Antiviral Research v.15 Effect of imexon treatment on Friend virus complex infection using genetically defined mice as a model for HIV-1 infection Morry,J.D.;Warren,R.P.;Okleberry,K.M.;Burger,R.A.;Chirigos,M.A.;Sidwell,R.W.
  13. Proc. Natl. Acad. Sci. U.S.A. v.71 Induction of endogenous virus and of thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virus Ostertag,W.;Roesler,G.;Krieg,C.J.;Kind,J.;Cole,T.;Crozier,T.;Gaedicke,G.;Steinheider,G.;Lluge,N.;Dube,S.
  14. Eur. J. Clinical Investigation v.9 Cooperation between viral oncogenes in avian erythroid and myeloid lukemia Beng,H.;Graf,T.
  15. Antimicrob. Agent Chemother v.31 Synergistic activity of granulocyte-macrophage colony-stimulating factor and 3'-azido-3'-deoxythimidine aginst human immunodeficiency virus in vitro Hammer,S.M.;Gillis,J.M.
  16. J. of Cell. Physiol. v.21 Spleenic erythroblast in Anemia-Inducing Friend Disease: a sourse of Cellular Studies of Erythropoietin-Mediated Differentiation Koury,M.J.;Sawyer,S.T.;Bondurant,M.C.
  17. Ann. Intern Med. v.108 Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi's sarcoma treated with zidovudine Walker,R.E.;Parker,R.I.;Kovacs,J.A.
  18. Proceeding of Asco v.8 Human recombinant erythropoiein (rHuEpo): A double-blind placebo controlled study in acquired immunodeficiency syndrome(AIDS) patients with anemia induced by disease and AZT Johnson,R.W.;Rudnick,S.A.;Raritan,N.J.
  19. Science v.260 How doses HIV cause AIDS? Weiss,R.A.
  20. Current Opinion in Immunology v.4 Molecular insights into human immunodeficiency virus type-1 pathogenesis Feinberg,M.B.;Greene,W.C.
  21. New Eng. J. Med. v.324 The molecular biology of human immunodeficiency virus type 1 infection Greene,W.C.